Skip to main content
. Author manuscript; available in PMC: 2017 Mar 14.
Published in final edited form as: ACS Biomater Sci Eng. 2016 Jan 18;2(3):385–392. doi: 10.1021/acsbiomaterials.5b00493

Figure 5.

Figure 5

(A) Resected liver as a percentage of body weight was not significant (p=0.3141). (B) Blood loss is not significant between groups, although it appears that hNP treatment trends towards a reduction in blood loss (p=0.7273). (C) Survival curve following liver trauma. (D)Survival of animals at one hour following liver trauma. The hemostatic nanoparticle (hNP) treatment (PLA-PEG-GRGDS nanoparticles) are significant compared with control nanoparticles (PLA-PEG-GRADSP) and saline (Kaplan Meier Estimate with 95% confidence bounds; Control vs. Saline, p= 0.0436; Control vs. hNP, p= 0.000271; hNPs vs. Saline, p= 0.0347)